PierianDx and Pillar Biosciences Announce Partnership to Support Precision Cancer Care

▴ PierianDx and Pillar Biosciences Announce Partnership to Support Precision Cancer Care
Under the agreement, PierianDx will integrate the Pillar Biosciences PiVAT® bioinformatics pipeline in the PierianDx environment to provide users with an accelerated implementation, including assay-specific variant filters, to produce best-

PierianDx, the leading clinical genomics informatics company, and Pillar Biosciences, a leading next-generation sequencing clinical oncology company, today announced a partnership that enables Pillar Biosciences to sell directly the PierianDx clinical genomic report in combination with its cancer profiling assays. Under the agreement, PierianDx will integrate the Pillar Biosciences PiVAT® bioinformatics pipeline in the PierianDx environment to provide users with an accelerated implementation, including assay-specific variant filters, to produce best-in-class clinical genomics reports and enable a complete sample-to-answer solution.

  

Laboratories worldwide use Pillar Biosciences’ assays to detect pivotal genetic variants for cancer and other diseases. Pillar Biosciences’ targeted panels utilize a proprietary enrichment chemistry, SLIMamp®, that enables rapid, automated amplification of overlapping amplicons in a single tube using minimal sample inputs. Pillar Biosciences’ complementary bioinformatics pipeline, PiVAT®, is optimized for efficiency, reducing reflex testing and enabling low-frequency variant calling for every type of variant while consuming limited computing resources. PierianDx provides the Clinical Genomics Workspace™, which consists of intuitive software and a robust clinical Knowledgebase that transforms variant information into a highly-structured and comprehensive physician-ready report.

 

Streamlining NGS along with clinical genomic interpretation and reporting, especially for sophisticated panels, remains time-consuming and challenging. By packaging the Pillar Biosciences panels with the PierianDx report, the result will be an out-of-the-box clinical genomic report that is optimized for each assay. Furthermore, the solution will be available to customers globally through secure, and in the case of European regions, Global Data Protection Regulation (GDPR)-compliant, cloud instances. As a result, laboratories and healthcare organizations worldwide will have a highly reliable method for providing these tests to enable precision diagnostics and treatments for their patients.

 

“The assays from Pillar Biosciences provide robust detection for all variant types in a simplified workflow,” states Gang Song, PhD, CEO of Pillar Biosciences. “By optimizing variant filters and integrating with the PiVAT pipeline, PierianDx is streamlining interpretation and reporting, which adds substantial value for our customers.”

 

Rakesh Nagarajan, MD, PhD and Founder and Chief Technical and Visionary Officer of PierianDx, adds, “We are thrilled to provide this support for the Pillar Biosciences assays. As the market shifts to more sensitive assays in the LDT space and leading assay manufacturers seek in vitro diagnostic (IVD) approval, we are committed to addressing challenges that arise from even greater complexity in the interpretation and reporting process.”

About PierianDx

Founded in 2014 out of Washington University in St. Louis, PierianDx is focused on advancing cancer diagnostics and making targeted therapeutics more accessible to healthcare systems, laboratories, and patients worldwide. Its industry-leading clinical genomics technologies, CAP and CLIA accredited laboratory, IVD-ready knowledgebase and reporting solution, and expertise deliver the most integrated, trusted, and collaborative approach across the clinical care spectrum. From genomic sequencing and biomedical informatics in the laboratory to reporting and decision support at the patient’s bedside, PierianDx drives the adoption of genomics in clinical care and accelerates the fight against somatic cancer and hereditary germline diseases. www.pieriandx.com.

 

About Pillar Biosciences

 Pillar Biosciences is a clinical cancer diagnostics company based in Boston, Massachusetts and Shanghai, China. Our automatable variant detection technologies deliver robust results with rapid turnaround times through streamlined NGS workflows. Our SLIMamp®– and PiVAT®-based products help high-throughput reference laboratories and clinical oncology laboratories make precision medicine practical by boosting their diagnostic productivity.

Tags : #pieriandx #biosciences #pieriandxandpillar #cancercare #pharmanews #latestpharmaupdates

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Our favourite cheese might just be a delicious way to boost our brainpower: Japanese Study Reveals Surprising FindingsSeptember 20, 2023
Our favourite cheese might just be a delicious way to boost our brainpower: Japanese Study Reveals Surprising FindingsSeptember 20, 2023
September 20, 2023
From Code to Care: How IT Firms Are Shaping India's HealthcareSeptember 20, 2023
Music and Sleep: Finding the Right Tune for Restful NightsSeptember 20, 2023
Addressing Child Mortality in Nandurbar: A Critical LookSeptember 20, 2023
Assam's Battle Against Toxic Magnesium Carbonate in Pan Masala BrandsSeptember 20, 2023
Surviving and Thriving: Essential Health Strategies for Young AdultsSeptember 20, 2023
Nasal Immunotherapy Shows Promise in Reducing Inflammation and Boosting Cognitive Function in Alzheimer's DiseaseSeptember 20, 2023
Unveiling the Health Benefits of Methi (Fenugreek) Seeds: An Indian Delight - Methi ke LadooSeptember 20, 2023
Atezolizumab-Bevacizumab Immunotherapy Breakthrough: Transforming Liver Cancer Treatment in IndiaSeptember 20, 2023
Health Scare at Kasturba Gandhi Balika Vidyalaya (KGBV), Bheemgal: 103 Students Admitted to HospitalSeptember 20, 2023
Healing Hands in Pain: The Emotional Fallout of Sexual Harassment on Women in HealthcareSeptember 20, 2023
Seeking Justice: The Tragic Case of Jaahnavi Kandula and the inhumanity of US policeSeptember 20, 2023
Nipah Virus Alert: Kerala Takes Swift Action to Contain OutbreakSeptember 20, 2023
An “Umbrella scheme” Rashtriya Arogya Nidhi (RAN): Providing Lifeline for Costly Medical TreatmentsSeptember 20, 2023
Electricity-Powered Biochip: A Game Changer in Healing Wounds FasterSeptember 20, 2023
Is Health Insurance really important?: A Guide for Young Adults in IndiaSeptember 20, 2023
Paryushana Parv: Exploring Jainism "Athai Tap" Fasting ritualSeptember 19, 2023
From Code to Care: How IT Firms Are Shaping India's Healthcare September 18, 2023